We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Par's Generic Ultracet Faces Challenge From Ortho-McNeil
Par's Generic Ultracet Faces Challenge From Ortho-McNeil
May 3, 2005
Par Pharmaceutical recently became the first company to launch a generic version of pain drug Ultracet, but its monopoly on the market was short-lived, as brand firm Johnson & Johnson (J&J) launched an authorized generic of the product one day later.